Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2016-08-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study (OxOPT-PCI) investigates if the use of blood flow measurements (namely measurement of fractional flow reserve (FFR)) and intravascular imaging (namely optical coherence tomography (OCT)) after the implantation of a stent can improve the treatment result for these patients. Both, FFR and OCT are being used already in daily clinical routing but their usefulness especially in combination is not clear. In order to standardise the optimisation procedure we developed a specific algorithm to make sure that all patients receive the same optimisation measures based on the assessment of FFR and OCT.
The benefit of this specific optimisation algorithm will be assessed by measuring 1) indices of coronary blood flow, 2) intravascular imaging at the end of the procedure, and 3) by contacting the patients 12 months after stenting to verify the clinical mid-term success.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Angiographic Coregistered Optical Coherence Tomography in Patients Undergoing PCI
NCT02919943
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
NCT02065102
Cardiovascular Patient Outcomes and Research Team Primary PCI Registry
NCT02201264
The Physiological Impact of CTO PCI on Coronary Pressure Measurements and Correlation in Donor Vessel
NCT02643940
Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study
NCT03646097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCI optimisation
Post PCI FFR below 0.9
Optimisation of the result of intracoronary stenting according to specific algorithm
No PCI optimisation
Post PCI FFR 0.9 or higher
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optimisation of the result of intracoronary stenting according to specific algorithm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* angiogram shows haemodynamically relevant lesion suitable for PCI and suitable for the use of intravascular imaging (OCT)
Exclusion Criteria
* ST-segment elevation myocardial infarction
* presentation with cardiogenic shock
* revascularization by mean of balloon angioplasty without stenting
* contraindications to adenosine
30 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oxford University Hospitals NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adrian Banning
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oxford University Hospital - NHS Trust
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.